Clinical Trial Update: Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) [Phase 3]

View source ↗

Summary

Follow-up study for patients who completed the Phase 3 HERCULES trial (ALX0681-C301) in acquired thrombotic thrombocytopenic purpura has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• ALX0681-C301

Snippet

Sponsor: Sanofi | Conditions: Acquired Thrombotic Thrombocytopenic Purpura | Phase 3 | Status: COMPLETED | Results posted: 2021-11-22